Titlebook: Hepatocellular Carcinoma; Diagnosis and Treatm Brian I. Carr Book 2010Latest edition Humana Press 2010 Carcinom.Cell Cycle Growth Inhibitor

fastness

Use of Imaging Techniques to Screen for Hepatocellular Carcinoma,c patient. Included are the fundamentals of using imaging in a surveillance program to monitor the progression of cirrhosis and to detect hepatocellular carcinoma (HCC). Imaging features are discussed that are useful in distinguishing among the various focal lesions that may be found in the cirrhoti

阻礙

MRI for Detection and Evaluation of Hepatocellular Carcinoma,diagnosis and following its response to management. In this chapter, we discuss features which allow distinction of HCC from other lesions in the cirrhotic liver, such as regenerative nodules, confluent fibrosis, and benign enhancing pseudonodules. One major strength of MRI is its use of multiple pu

煩憂

Interdict

直言不諱

無能力之人

Resection of Hepatocellular Carcinoma, New strategies, such as portal vein embolization and combined resection/ablation, have extended the indication of hepatic resection for HCC. Laparoscopic hepatectomy may further enhance the benefit of resection for HCC by reducing blood loss and morbidity. However, a high postoperative recurrence r

Decrepit

Liver Transplantation for Hepatocellular Carcinoma, resection or ablation can provide cure for a small minority of patients with this disease, the vast majority develop HCC in the setting of cirrhosis. Thus, standard therapies aimed at localizable tumor(s) may fail to treat synchronous lesions present in other parts of the liver and do nothing to ad

噴出

Living Donor Liver Transplantation for Hepatocellular Carcinoma,an ideal treatment for unresectable hepatocellular carcinoma (HCC), since it provides the potential for cure of both the HCC and the underlying liver disease. Although the early results of liver transplantation for HCC were disappointing, emerging Milan criteria in 1996 improved the outcome of liver

支形吊燈

Brian I. CarrCaptures the recent exciting changes in the understanding of diagnostic methods, novel therapeutics and the day-to-day management of hepatocellular cancer.Discusses changes in evaluation of tumor resp

圓桶

Current Clinical Oncologyhttp://image.papertrans.cn/h/image/425735.jpg